Ipsen S.A. (I7G)
FSX
Real-time Data
06:00 AM
Day's Range
168.2052 wk Range
101.30Overview - I7G - Ipsen S.A.
Key Statistics
Valuation
Enterprise Value
12.53B
P/E (Trailing)
‪26.77‬
Price / Sales (TTM)
‪3.18‬
Price / Book
‪2.89‬
EV / EBITDA
‪8.62‬
Profitability
Profit Margin
‪11.94%‬
Operating Margin
‪28.48%‬
Return on Assets
‪10.27%‬
Return on Equity
‪11.44%‬
Ownership
Shares Outstanding
82.60M
Float
29.96M
Held by Insiders
‪57.64%‬
Held by Institutions
‪21.27%‬
Price stats
Beta
‪0.32‬
50-Day Avg
‪161.44‬
200-Day Avg
‪149.84‬
Dividends
Payout Ratio
‪25.89%‬
Frequency
Annual
Peers - I7G - Ipsen S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- I7GFSXIpsen S.A.13.33BMarket Cap+34.32%52-week change30.32P/E (Trailing)‪11.28%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.08BMarket Cap+30.19%52-week change43.54P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation112.76BMarket Cap+26.87%52-week change35.52P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.21BMarket Cap+21.70%52-week change23.68P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR59.99BMarket Cap+22.63%52-week change25.32P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG41.97BMarket Cap+19.44%52-week change57.83P/E (Trailing)‪14.57%‬Profit Margin
- H6D0FSXHaleon plc38.20BMarket Cap+3.66%52-week change20.60P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - I7G - Ipsen S.A.
About
Ipsen S.A. is a French biopharmaceutical company headquartered in Paris, specializing in the development and commercialization of transformative medicines across three core therapeutic areas: oncology, rare diseases, and neuroscience. Founded in 1929 by Dr. Henri Beaufour as a family business, it has evolved over…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
